The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Targeting Strategies for Tissue-Specific Drug Delivery
Open accessAbstract
Off-target effects of systemically administered drugs have been a major hurdle in designing therapies with desired efficacy and acceptable toxicity. Developing targeting strategies to enable site-specific drug delivery holds promise in reducing off-target effects, decreasing unwanted toxicities, and thereby enhancing a drug's therapeutic efficacy. Over the past three decades, a large body of literature has focused on understanding the biological barriers that hinder tissue-specific drug delivery and strategies to overcome them. These efforts have led to several targeting strategies that modulate drug delivery in both the preclinical and clinical settings, including small molecule-, nucleic acid-, peptide-, antibody-, and cell-based strategies. Here, we discuss key advances and emerging concepts for tissue-specific drug delivery approaches and their clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Impact of high-throughput screening in biomedical research
Macarron, R., Banks, M. N., Bojanic, D., Burns, D. J., Cirovic, D. A., Garyantes, T., Green, D. V. S., Hertzberg, R. P., Janzen, W. P., Paslay, J. W., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3368 · Cited by 1,364
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Leukocyte Migration into Inflamed Tissues
Nourshargh, S., & Alon, R. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.008 · Cited by 1,167
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., & Johnson, K. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-309 · Cited by 1,027
Xue, J., Zhao, Z., Zhang, L., Xue, L., Shen, S., Wen, Y., Wei, Z., Wang, L., Kong, L., Sun, H., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.54 · Cited by 959
Self-citationMurdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908201106 · Cited by 812
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Harding, F. A., Stickler, M. M., Razo, J., & DuBridge, R. (2010) · mAbs · doi:10.4161/mabs.2.3.11641 · Cited by 737
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Tang, L., Zheng, Y., Melo, M. B., Mabardi, L., Castaño, A. P., Xie, Y.-Q., Li, N., Kudchodkar, S. B., Wong, H. C., Jeng, E. K., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4181 · Cited by 660
Sackstein, R., Merzaban, J. S., Cain, D. W., Dagia, N. M., Spencer, J. A., Lin, C. P., & Wohlgemuth, R. (2008) · Nature Medicine · doi:10.1038/nm1703 · Cited by 641
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
Self‐Assembled Peptide‐Based Nanomaterials for Biomedical Imaging and Therapy
Qi, G., Gao, Y., Wang, L., & Wang, H. (2018) · Advanced Materials · doi:10.1002/adma.201703444 · Cited by 527
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
Wang, C., Sun, W., Ye, Y., Hu, Q., Bomba, H. N., & Gu, Z. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0011 · Cited by 526
Drug discovery by dynamic combinatorial libraries
Ramström, O., & Lehn, J.-M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd704 · Cited by 511
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
HER2 expression status in diverse cancers: review of results from 37,992 patients
Yan, M., Schwaederle, M., Arguello, D., Millis, S. Z., Gatalica, Z., & Kurzrock, R. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9552-6 · Cited by 483
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 444
Self-citationPolymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Maldonado, R. A., LaMothe, R. A., Ferrari, J. D., Zhang, A.-H., Rossi, R. J., Kolte, P. N., Griset, A. P., O’Neil, C., Altreuter, D. H., Browning, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408686111 · Cited by 441
Seaman, S., Zhu, Z., Saha, S., Zhang, X. M., Yang, M. Y., Hilton, M. B., Morris, K., Szot, C., Morris, H., Swing, D. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.03.005 · Cited by 423
Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy
Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399
Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.007 · Cited by 397
Self-citationRecent development of biotin conjugation in biological imaging, sensing, and target delivery
Ren, W. X., Han, J., Uhm, S., Jang, Y. J., Kang, C., Kim, J.-H., & Kim, J. S. (2015) · Chemical Communications · doi:10.1039/c5cc03075g · Cited by 393
Self-citationRed blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
Brenner, J. S., Pan, D. C., Myerson, J. W., Marcos-Contreras, O. A., Villa, C. H., Patel, P., Hekierski, H., Chatterjee, S., Tao, J.-Q., Parhiz, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05079-7 · Cited by 363
Self-citationAnselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 355
Self-citationThe folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350
Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors
Deshayes, S., Cabral, H., Ishii, T., Miura, Y., Kobayashi, S., Yamashita, T., Matsumoto, A., Miyahara, Y., Nishiyama, N., & Kataoka, K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406406h · Cited by 348
Ledermann, J. A., Canevari, S., & Thigpen, T. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv250 · Cited by 347
Challenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 307
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
Juliano, R., Bauman, J., Kang, H., & Ming, X. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900093r · Cited by 304
A Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
Krall, N., Pretto, F., Decurtins, W., Bernardes, G. J. L., Supuran, C. T., & Neri, D. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310709 · Cited by 299
Mannose-targeted systems for the delivery of therapeutics
Irache, J. M., Salman, H. H., Gamazo, C., & Espuelas, S. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.703 · Cited by 293
Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic
Wu, H.-H., Zhou, Y., Tabata, Y., & Gao, J.-Q. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.019 · Cited by 288
Chu, D., Gao, J., & Wang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b05583 · Cited by 283
Rossin, R., Versteegen, R. M., Wu, J., Khasanov, A., Wessels, H. J., Steenbergen, E. J., ten Hoeve, W., Janssen, H. M., van Onzen, A. H. A. M., Hudson, P. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03880-y · Cited by 277
Jiang, X., Xin, H., Ren, Q., Gu, J., Zhu, L., Du, F., Feng, C., Xie, Y., Sha, X., & Fang, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.094 · Cited by 270
Lee, C., Hwang, H. S., Lee, S., Kim, B., Kim, J. O., Oh, K. T., Lee, E. S., Choi, H., & Youn, Y. S. (2017) · Advanced Materials · doi:10.1002/adma.201605563 · Cited by 246
Self-citationMamot, C., Ritschard, R., Wicki, A., Stehle, G., Dieterle, T., Bubendorf, L., Hilker, C., Deuster, S., Herrmann, R., & Rochlitz, C. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70476-x · Cited by 244
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
Eiber, M., Fendler, W. P., Rowe, S. P., Calais, J., Hofman, M. S., Maurer, T., Schwarzenboeck, S. M., Kratowchil, C., Herrmann, K., & Giesel, F. L. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.186767 · Cited by 241
Development of macromolecular prodrug for rheumatoid arthritis
Yuan, F., Quan, L.-D., Cui, L., Goldring, S. R., & Wang, D. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.03.006 · Cited by 239
Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
Anami, Y., Yamazaki, C. M., Xiong, W., Gui, X., Zhang, N., An, Z., & Tsuchikama, K. (2018) · Nature Communications · doi:10.1038/s41467-018-04982-3 · Cited by 226
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
Zhu, G., Niu, G., & Chen, X. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00291 · Cited by 213
Levy, O., Zhao, W., Mortensen, L. J., LeBlanc, S., Tsang, K., Fu, M., Phillips, J. A., Sagar, V., Anandakumaran, P., Ngai, J., et al. (2013) · Blood · doi:10.1182/blood-2013-04-495119 · Cited by 211
Nanoparticle‐Laden Macrophages for Tumor‐Tropic Drug Delivery
Zhang, W., Wang, M., Tang, W., Wen, R., Zhou, S., Lee, C., Wang, H., Jiang, W., Delahunty, I. M., Zhen, Z., et al. (2018) · Advanced Materials · doi:10.1002/adma.201805557 · Cited by 209
Lu, Y., Hu, Q., Jiang, C., & Gu, Z. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.11.010 · Cited by 202
Hyaluronic Acid-Based Nanomaterials for Cancer Therapy
Kim, J. H., Moon, M. J., Kim, D. Y., Heo, S. H., & Jeong, Y. Y. (2018) · Polymers · doi:10.3390/polym10101133 · Cited by 199
Self-citationCell‐Based Drug Delivery Devices Using Phagocytosis‐Resistant Backpacks
Doshi, N., Swiston, A. J., Gilbert, J. B., Alcaraz, M. L., Cohen, R. E., Rubner, M. F., & Mitragotri, S. (2011) · Advanced Materials · doi:10.1002/adma.201004074 · Cited by 191
Self-citationMacrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190
Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
Williams, R. M., Shah, J., Ng, B. D., Minton, D. R., Gudas, L. J., Park, C. Y., & Heller, D. A. (2015) · Nano Letters · doi:10.1021/nl504610d · Cited by 185
Bisphosphonate conjugation for bone specific drug targeting
Farrell, K. B., Karpeisky, A., Thamm, D. H., & Zinnen, S. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.06.007 · Cited by 182
Computational design of peptide ligands
Vanhee, P., van der Sloot, A. M., Verschueren, E., Serrano, L., Rousseau, F., & Schymkowitz, J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.01.004 · Cited by 166
Damelin, M., Bankovich, A., Bernstein, J., Lucas, J., Chen, L., Williams, S., Park, A., Aguilar, J., Ernstoff, E., Charati, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2611 · Cited by 163
Anselmo, A. C., Gilbert, J. B., Kumar, S., Gupta, V., Cohen, R. E., Rubner, M. F., & Mitragotri, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.027 · Cited by 159
Self-citationHuo, M., Zhao, Y., Satterlee, A., Wang, Y., Xu, Y., & Huang, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.013 · Cited by 159
Pishesha, N., Bilate, A. M. B., Wibowo, M. C., Huang, N.-J., Li, Z., Deshycka, R., Bousbaine, D., Li, H., Patterson, H. C., Dougan, S. K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701746114 · Cited by 159
Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of Somatostatin
Pless, J., Bauer, W., Briner, U., Doepfner, W., Marbach, P., Maurer, R., Petcher, T. J., Reubi, J. C., & Vonderscher, J. (1986) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528609087432 · Cited by 155
Zhao, Z., Ukidve, A., Gao, Y., Kim, J., & Mitragotri, S. (2019) · Science Advances · doi:10.1126/sciadv.aax9250 · Cited by 155
Self-citationDelivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse
Choi, M.-R., Bardhan, R., Stanton-Maxey, K. J., Badve, S., Nakshatri, H., Stantz, K. M., Cao, N., Halas, N. J., & Clare, S. E. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-012-0029-9 · Cited by 154
Engineered immune cells as highly sensitive cancer diagnostics
Aalipour, A., Chuang, H., Murty, S., D’Souza, A. L., Park, S.-M., Gulati, G. S., Patel, C. B., Beinat, C., Simonetta, F., Martinić, I., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0064-8 · Cited by 149
Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping
Zheng, Z., Li, Z., Xu, C., Guo, B., & Guo, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.021 · Cited by 147
Drug delivery with living cells
Fliervoet, L. A. L., & Mastrobattista, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.021 · Cited by 143
Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy
Chu, D., Zhao, Q., Yu, J., Zhang, F., Zhang, H., & Wang, Z. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500998 · Cited by 139
Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia
Hou, J., Yang, X., Li, S., Cheng, Z., Wang, Y., Zhao, J., Zhang, C., Li, Y., Luo, M., Ren, H., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau8301 · Cited by 124
A chemical approach for global protein knockdown from mice to non-human primates
Sun, X., Wang, J., Yao, X., Zheng, W., Mao, Y., Lan, T., Wang, L., Sun, Y., Zhang, X., Zhao, Q., et al. (2019) · Cell Discovery · doi:10.1038/s41421-018-0079-1 · Cited by 118
Peck, M. C., Rothenberg, M. E., Deng, R., Lewin‐Koh, N., She, G., Kamath, A. V., Carrasco‐Triguero, M., Saad, O. M., Castro, A., Teufel, L. U., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02588-18 · Cited by 118
Stem Cells Loaded with Nanoparticles as a Drug Carrier for In Vivo Breast Cancer Therapy
Cao, B., Yang, M., Zhu, Y., Qu, X., & Mao, C. (2014) · Advanced Materials · doi:10.1002/adma.201401550 · Cited by 117
Lapusan, S., Vídriales, M., Thomas, X., de Botton, S., Vekhoff, A., Tang, R., Dumontet, C., Morariu-Zamfir, R., Lambert, J. M., Ozoux, M., et al. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9670-0 · Cited by 108
MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery
Oller‐Salvia, B., Sánchez‐Navarro, M., Ciudad, S., Guiu, M., Arranz‐Gibert, P., Garcia, C., Gomis, R. R., Cecchelli, R., García, J., Giralt, E., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508445 · Cited by 99
Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase
Lorentz, K. M., Kontos, S., Diaceri, G., Henry, H., & Hubbell, J. A. (2015) · Science Advances · doi:10.1126/sciadv.1500112 · Cited by 93
Nanna, A. R., Li, X., Walseng, E., Pedzisa, L., Goydel, R. S., Hymel, D., Burke, T. R., Roush, W. R., & Rader, C. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01257-1 · Cited by 93
Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models
Papa, A., Jiang, A. R., Korin, N., Chen, M. B., Langan, E. T., Waterhouse, A., Nash, E., Caroff, J., Graveline, A. R., Vernet, A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5898 · Cited by 86
Pacioni, S., D’Alessandris, Q. G., Giannetti, S., Morgante, L., Pascalis, I. D., Coccè, V., Bonomi, A., Pascucci, L., Alessandri, G., Pessina, A., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0185-z · Cited by 79
Sano, R., Krytska, K., Larmour, C., Raman, P., Martínez, D., Ligon, G. F., Lillquist, J. S., Cucchi, U., Orsini, P., Rizzi, S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau9732 · Cited by 70
Application of glycosylation in targeted drug delivery
Chen, F., & Huang, G. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111612 · Cited by 70
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery
Lingasamy, P., Tobi, A., Haugas, M., Hunt, H., Paiste, P., Asser, T., Rätsep, T., Kotamraju, V. R., Bjerkvig, R., & Teesalu, T. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119373 · Cited by 69
A Cell-Penetrating Peptide Targeting AAC-11 Specifically Induces Cancer Cells Death
Jagot-Lacoussiere, L., Pasquereau-Kotula, E., Villoutreix, B. O., Bruzzoni‐Giovanelli, H., & Poyet, J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0302 · Cited by 58
Lv, Q., Yang, J., Zhang, R., Yang, Z., Yang, Z., Wang, Y., Xu, Y., & He, Z. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00026 · Cited by 49
Novel Anti-TM4SF1 Antibody–Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature
Visintin, A., Knowlton, K. M., Tyminski, E., Lin, C., Zheng, X., Marquette, K., Jain, S., Tchistiakova, L., Li, D., O’Donnell, C. J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0188 · Cited by 45
Antibody–Drug Conjugates with Pyrrole‐Based KSP Inhibitors as the Payload Class
Lerchen, H., Wittrock, S., Stelte‐Ludwig, B., Sommer, A., Berndt, S., Griebenow, N., Rebstock, A., Johannes, S., Cancho‐Grande, Y., Mahlert, C., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807619 · Cited by 41
In Vivo Translation of Peptide-Targeted Drug Delivery Systems Discovered by Phage Display
Newman, M. R., & Benoit, D. S. W. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00285 · Cited by 37
Singh, H., Kim, S. J., Kang, D. H., Kim, H. R., Sharma, A. K., Kim, W., Kang, C., & Kim, J. S. (2018) · Chemical Communications · doi:10.1039/c8cc05175e · Cited by 29
Self-citationLigands for Targeted Drug Delivery and Applications
Kapoor, D. U., Bhatt, S., Kumar, M., Maheshwari, R., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817909-3.00008-x · Cited by 21
Deadly DAaRTS destroy cancer cells via a tumor microenvironment–mediated trigger
McCann, J. V., Null, J. L., & Dudley, A. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121527 · Cited by 12
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“15,16 On the basis of these strategies, functional materials with small size, tailored architecture and therapeutic motifs that facilitate the targeted drug delivery are widely engineered.”
BackgroundConnecting copper and cancer: from transition metal signalling to metalloplasia
Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S., et al. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00417-2 · Cited by 1,298
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Biomedicine Meets Fenton Chemistry
Tang, Z., Zhao, P., Wang, H., Liu, Y., & Bu, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00977 · Cited by 745
Metadata
- Authors
- Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 181
- Issue
- 1
- Pages
- 151-167
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3014461065
- Cited by
- 1,099
- References
- 96
- FWCI
- 24.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.